US Oncology Launches CRO

Wednesday, April 8, 2009 08:00 AM

Cancer treatment and research network US Oncology has established a contract research organization (CRO), formalizing many of the CRO services that the organization already provided.

US Oncology Clinical Development will provide oncology-specific CRO support for phase I to phase IV clinical trials, including physician advisory boards, safety data collection and regulatory submission, medical writing and protocol development, biostatistics, site selection and payments, and central institution review board (IRB).

"We have built an experienced team that enhances our ability to serve our clients for all of their oncology clinical trial needs," said Steve Smith, vice president and general manager of Research and Personalized Science for US Oncology, in a company statement. “We will leverage all of the strengths of the US Oncology network and its proven history of accrual performance and commitment to quality."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs